FDA.reportPublic FDA data

LEVOTHYROXINE SODIUM ANHYDROUS

Substance profile for UNII 054I36CPMN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for LEVOTHYROXINE SODIUM ANHYDROUS
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
054I36CPMN
Preferred term
LEVOTHYROXINE SODIUM ANHYDROUS
Registry number
55-03-8
EC number
200-221-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C15H10I4NO4.Na
Chemical structure for LEVOTHYROXINE SODIUM ANHYDROUS
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
YDTFRJLNMPSCFM-YDALLXLXSA-M
SMILES
[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O
RxCUI
1372638
PubChem
0
INN ID
453

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchYDTFRJLNMPSCFM-YDALLXLXSA-Mpubchem.ncbi.nlm.nih.gov/#query=YDTFRJLNMPSCFM-YDALLXLXSA-M
RxNorm1372638mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1372638
FDA Substance Registration System054I36CPMNprecision.fda.gov/uniisearch/srs/unii/054I36CPMN
European Community number200-221-4commonchemistry.cas.org/results?q=200-221-4

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
Levothyroxine Sodium Tablets, USP4
Levothyroxine Sodium Tablets, USP3
Levothyroxine Sodium Tablets, USP2
Levothyroxine Sodium Tablets, USP2
Levothyroxine Sodium Tablets, USP2
Levothyroxine Sodium Tablets, USP2
Levothyroxine Sodium Tablets, USP2
Levothyroxine Sodium Tablets, USP2
LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]3
LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]2
LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]1